Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

Consistently Good Clinical Response in Patients with Early Axial Spondyloarthritis After 3 Years of Continuous Treatment with Etanercept: Longterm Data of the ESTHER Trial

Asdas: Ankylosing Spondylitis Disease Activity Score

Video Abstract: Simplified Ankylosing Spondylitis Disease Activity Score ( SASDAS) Versus ASDAS

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

Scatter plot of patient data showing the change in SASDAS compared with

Bland-Altman plots for (A) baseline pooled treatment; (B) week 12 PBO;

Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two

PDF) Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

Video Abstract: Simplified Ankylosing Spondylitis Disease Activity Score ( SASDAS) Versus ASDAS

PDF) Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis

Correlation of the SASDAS with measures of disease assessment